Unbound MEDLINE

Transjugular intrahepatic portosystemic shunt creation as treatment for refractory chylous ascites and chylothorax in a patient with cirrhosis. Journal of vascular and interventional radiology : JVIR. [J Vasc Interv Radiol] Journal article

 
TitleTransjugular intrahepatic portosystemic shunt creation as treatment for refractory chylous ascites and chylothorax in a patient with cirrhosis.
Author(s)Kinney TB, Ferrara SL, Miller FJ, Roberts AC, Hassanein T 
InstitutionDepartment of Radiology, University of California San Diego Medical Center, 200 West Arbor Street, mail code 8756, San Diego, California 92101, USA. tbkinney@ucsd.edu
SourceJ Vasc Interv Radiol 2004 Jan; 15(1 Pt 1):85-9.
MeSHChest Tubes
Chylothorax
Chylous Ascites
Humans
Liver Cirrhosis
Male
Middle Aged
Paracentesis
Portasystemic Shunt, Transjugular Intrahepatic
Treatment Outcome
AbstractThe etiology of chylothorax is usually considered to consist of four major categories: tumors, trauma, idiopathic conditions, and miscellaneous conditions. It appears that chylothorax is a rare and underreported manifestation of cirrhosis resulting from transdiaphragmatic passage of chylous ascites. This condition can be debilitating as a result of respiratory compromise from a large volume of pleural fluid, as well as metabolic derangements, malnutrition, and immunologic impairment from loss of vital lymphatic constituents. Herein the authors present a case of a 46-year-old male patient with cirrhosis and complications of high-volume chylous ascites and chylothorax who was successfully treated with creation of a transjugular intrahepatic portosystemic shunt.
Languageeng
Pub Type(s)Case Reports
Journal Article
PubMed ID14709693
  
Advertise on this site.